Latest News about AVIR
Recent news which mentions AVIR
3 COVID-19 Pill Stocks to Watch
October 16, 2021
From Motley Fool
The success of Merck’s antiviral—and other COVID-19 pills in development—may depend on how quickly people start taking them
October 14, 2021
From MarketWatch
3 COVID Stocks That Can Turn $1,000 Into $10,000
October 12, 2021
From Motley Fool
Molnupiravir? Not So Fast. What About Tollovir? — Here's Why You Should Know What That Means
October 12, 2021
From Benzinga
From Motley Fool
10 Health Care Stocks With Unusual Options Alerts In Today's Session
October 08, 2021
From Benzinga
From Motley Fool
Why Novavax Stock Plunged in September
October 06, 2021
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2021
October 05, 2021
From Benzinga
Which COVID-19 Pill Stock Is the Best Buy?
October 05, 2021
From Motley Fool
2 Best Biotech Stocks to Buy In October
October 04, 2021
From Motley Fool
3 Stocks That Might Soar With Pills for COVID
October 03, 2021
From Motley Fool
Here Are the Leaders in the Race to Develop a COVID-19 Pill
October 03, 2021
From Motley Fool
Mid-Afternoon Market Update: Nasdaq Rises Over 100 Points; Biomerica Shares Spike Higher
October 01, 2021
From Benzinga
From MarketWatch
12 Health Care Stocks Moving In Friday's Intraday Session
October 01, 2021
From Benzinga
Mid-Day Market Update: Dow Surges 300 Points; Omeros Shares Plummet
October 01, 2021
From Benzinga
Why Atea Pharmaceutical Stock Is Ripping Higher Today
October 01, 2021
From Motley Fool
Mid-Morning Market Update: Markets Mostly Higher; ISM Manufacturing Index Rises In September
October 01, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
September 30, 2021
From Benzinga
48 Biggest Movers From Yesterday
September 21, 2021
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
September 20, 2021
From Benzinga
35 Stocks Moving In Monday's Mid-Day Session
September 20, 2021
From Benzinga
7 Biotech Stocks to Buy That Have Millionaire-Maker Potential
September 10, 2021
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2021
September 09, 2021
From Benzinga
Atea Unveils Trial Amendments, New Data For COVID-19 Program
August 13, 2021
Tickers
AVIR
From Benzinga
Atea Pharmaceuticals Inc (AVIR) Q2 2021 Earnings Call Transcript
August 13, 2021
Tickers
AVIR
From Motley Fool
12 Health Care Stocks Moving In Thursday's After-Market Session
August 12, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.